T-Cell overreaction may worsen COVID-19, small study hints
NCT ID NCT04410432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 39 hospitalized COVID-19 patients to see if a strong T-cell immune response is linked to worse symptoms. Researchers measured specific immune cells and chemicals in the blood. The goal was to understand why some patients get much sicker, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Dijon Bourogne
Dijon, 21000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?